Latest News

GeneLancet Biosciences Inc. has appointed Leonid Beigelman,...

Click Here

Latest News

GeneLancet presented at 2023 26th ASGCT annual...

Click Here

Ultra-Pure Ligated sgRNA(LgRNA) and Conjugates and LgRNA Arrayed Libraries

Pure. Precise. Efficient.

Click Here

Therapeutic LgRNA Guided Gene Editors

Gene editing platform for advancing cures for various diseases

Click Here
genes with medicines and a pie graph background

IntroducingGeneLancet Biosciences

GeneLancet is a gene editing company that has developed proprietary LgRNA technology, which enables precise gene editing with ultra-pure, high quality ligated single molecule guide RNAs (LgRNA). LgRNAs have enhanced activity at challenging targeting sites.

GeneLancet is developing LgRNA-conjugates-directed CRISPR gene editing.  Our platform provides significant benefits in developing therapeutics for rare monogenic conditions, cancer, viral infectious diseases and other diseases with significant unmet needs.